Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 4,317,000 | 2,507,000 | 4,154,000 | 4,871,000 | 4,676,000 |
| Cost of Goods | 1,340,000 | 911,000 | 1,465,000 | 1,568,000 | 1,476,000 |
| Gross Profit | 2,977,000 | 1,596,000 | 2,689,000 | 3,303,000 | 3,200,000 |
| Operating Expenses | 2,214,000 | 2,170,000 | 2,197,000 | 2,329,000 | 2,320,000 |
| Operating Income | 763,000 | -574,000 | 492,000 | 974,000 | 880,000 |
| Other Income | 89,000 | -261,000 | 125,000 | 136,000 | 313,000 |
| Pre-tax Income | 852,000 | -835,000 | 617,000 | 1,110,000 | 1,193,000 |
| Income Tax | 68,000 | -346,000 | 193,000 | 256,000 | 328,000 |
| Net Income Continuous | 643,000 | -505,000 | 338,000 | 667,000 | 714,000 |
| Net Income Discontinuous | 47,000 | N/A | N/A | N/A | N/A |
| Net Income | $690,000 | $-134,000 | $338,000 | $667,000 | $714,000 |
| EPS Basic Total Ops | 0.35 | -0.06 | 0.17 | 0.34 | 0.36 |
| EPS Basic Continuous Ops | 0.33 | -0.26 | 0.17 | 0.34 | 0.36 |
| EPS Basic Discontinuous Ops | 0.02 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.35 | -0.06 | 0.17 | 0.34 | 0.36 |
| EPS Diluted Continuous Ops | 0.33 | -0.24 | 0.17 | 0.33 | 0.36 |
| EPS Diluted Discontinuous Ops | 0.02 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $979,000 | $-340,000 | $722,000 | $1,211,000 | $1,106,000 |